Stammdaten
Madrigal Pharmaceuticals, Inc., ein klinisches Biopharmaunternehmen, konzentriert sich auf die Entwicklung und Vermarktung von therapeutischen Kandidaten zur Behandlung von kardiovaskulären, metabolischen und Lebererkrankungen. Das Leitprodukt ist Resmetirom, ein lebergerichteter selektiver Schilddrüsenhormonrezeptor-β-Agonist, der sich in Phase-III-Kliniktests zur Behandlung der nicht-alkoholischen Steatohepatitis befindet. Das Unternehmen entwickelt auch MGL-3745, eine Backup-Substanz zu Resmetirom. Es hat eine Forschungs-, Entwicklungs- und Vermarktungsvereinbarung mit Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. ist in West Conshohocken, Pennsylvania, ansässig.
Unternehmen & Branche
| Name | MADRIGAL PHARMACEUTICALS, INC. |
|---|---|
| Ticker | MDGL |
| CIK | 0001157601 |
| Börse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 558868105 |
|---|---|
| ISIN | US5588681057 |
| Typ | Common Stock |
| Marktkapitalisierung | 12,26 Mrd. USD |
| Beta | -1,08 |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 200 BARR HARBOR DRIVE, SUITE 400, 19428 WEST CONSHOHOCKEN, PA |
| Telefon | 404-380-9263 |
| EIN (IRS) | 00-0000000 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Large accelerated filer |
| Frühere Namen | SYNTA PHARMACEUTICALS CORP (bis 2016) |
Bewertung
| KBV (P/B) | 20,34 vs. 7,39 (2021) ▲ |
|---|---|
| KUV (P/S) | 12,79 |
| FCF-Rendite | -1,6 % vs. -12,7 % (2021) ▲ |
Qualität & Bilanz
| Operative Marge | -31,3 % |
|---|---|
| Nettomarge | -30,1 % |
| ROIC | -30,3 % vs. -122,8 % (2021) ▲ |
| Zinsdeckungsgrad | -13,5 |
| Forderungslaufzeit (DSO) | 51 T |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 7,39 | 26,62 | 11,35 | 9,00 | 22,07 | 22,56 | |
| KUV (P/S) | – | – | – | 37,69 | 13,88 | 10,83 | |
| FCF-Rendite | -12,7 % | -4,3 % | -7,1 % | -6,7 % | -1,4 % | -2,2 % | |
| Qualität & Bilanz | |||||||
| Operative Marge | – | – | – | -276,4 % | -31,3 % | -27,7 % | |
| Nettomarge | – | – | – | -258,6 % | -30,1 % | -27,3 % | |
| ROIC | -122,8 % | -119,4 % | -71,5 % | -53,3 % | -30,3 % | -34,7 % | |
| Zinsdeckungsgrad | – | -74,1 | -29,9 | -33,9 | -13,5 | -11,7 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
MDGL
MADRIGAL PHARMACEUTICALS, INC.
Effektiv
Schwach
Handelsvolumen
Hoch
Insider
0,0
Keine Insider-Käufe
Institutionell
29,0
64 neu, 133 erhöht, -1710144K $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)
Score-Verlauf (90 Tage)
Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 512.12 | +4.8 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 500.93 | +7.2 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 526.57 | EMA50: 514.81 | |
| MACD-Histogramm | Bullisch | 10 % | 1.458 | Bullisch | |
| RSI(14) | Neutral | 10 % | 55.5 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 49.4 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 15.8 | +DI: 21.2 / −DI: 17.6 | |
| Z-Score(60) | Neutral | 5 % | 1.08 | In Range | |
| 52W-Position | Neutral | 5 % | 78.9 % | Hoch 602.83 / Tief 289.88 | |
| Bollinger(20,2σ) | Neutral | 5 % | 67.3 % | Upper 561.06 / Mid 524.03 / Lower 487.00 | |
| LinReg-Slope(60) | Neutral | 10 % | +0.0542 | R²=0.00 / annualisiert +2.7 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | Soergel David | Officer, Chief Medical Officer | Open Market Sale | -1.042 | 495,74 | -516.561,08 | -62,1% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -40 | 506,68 | -20.267,00 | -2,4% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -1.497 | 517,59 | -774.835,37 | -93,2% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -782 | 518,76 | -405.668,76 | -48,8% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -723 | 516,87 | -373.693,97 | -45,0% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -657 | 515,92 | -338.960,69 | -40,8% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -610 | 511,40 | -311.951,99 | -37,5% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -439 | 512,50 | -224.988,47 | -27,1% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -343 | 514,67 | -176.531,50 | -21,2% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -320 | 508,24 | -162.637,44 | -19,6% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -151 | 510,36 | -77.064,04 | -9,3% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -80 | 519,98 | -41.598,40 | -5,0% | |
| 2026-05-22 | Levy Richard S | Director | Open Market Sale | -40 | 512,97 | -20.518,80 | -2,5% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -40 | 425,08 | -17.003,20 | -2,0% | |
| 2026-03-06 | Sibold William John | Director, Officer, President and CEO | Open Market Sale | -1.663 | 431,94 | -718.316,22 | -86,4% | |
| 2026-03-06 | Taub Rebecca | Director | Open Market Sale | -491 | 431,94 | -212.082,54 | -25,5% | |
| 2026-03-06 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -419 | 431,94 | -180.982,86 | -21,8% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -120 | 430,90 | -51.708,40 | -6,2% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -116 | 432,56 | -50.176,48 | -6,0% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -80 | 436,69 | -34.935,20 | -4,2% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -80 | 435,32 | -34.825,20 | -4,2% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -80 | 427,85 | -34.227,60 | -4,1% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -40 | 437,65 | -17.506,00 | -2,1% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -40 | 429,58 | -17.183,20 | -2,1% | |
| 2026-03-06 | Kelley Shannon T | Officer, General Counsel | Open Market Sale | -360 | 431,94 | -155.498,40 | -18,7% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -646 | 431,94 | -279.033,24 | -33,6% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -420 | 426,86 | -179.282,80 | -21,6% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -160 | 434,20 | -69.472,00 | -8,4% | |
| 2026-03-06 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -160 | 429,00 | -68.639,20 | -8,3% | |
| 2026-03-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -1.183 | 427,21 | -505.389,43 | -60,8% | |
| 2026-01-26 | Sibold William John | Director, Officer, President and CEO | Open Market Sale | -1.577 | 492,42 | -776.546,34 | -93,4% | |
| 2026-01-26 | Taub Rebecca | Director | Open Market Sale | -647 | 492,42 | -318.595,74 | -38,3% | |
| 2026-01-26 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -570 | 494,59 | -281.916,30 | -33,9% | |
| 2026-01-26 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -340 | 492,42 | -167.422,80 | -20,1% | |
| 2026-01-20 | Kelley Shannon T | Officer, General Counsel | Open Market Sale | -429 | 501,40 | -215.100,60 | -25,9% | |
| 2026-01-20 | Kelley Shannon T | Officer, General Counsel | Open Market Sale | -263 | 490,77 | -129.072,51 | -15,5% | |
| 2026-01-20 | Taub Rebecca | Director | Open Market Sale | -2.238 | 490,77 | -1.098.343,26 | -132,1% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -960 | 512,02 | -491.537,18 | -59,1% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -937 | 514,63 | -482.207,47 | -58,0% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -913 | 526,05 | -480.281,37 | -57,8% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -732 | 522,98 | -382.822,60 | -46,1% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -588 | 521,95 | -306.908,66 | -36,9% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -554 | 529,28 | -293.221,84 | -35,3% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -539 | 519,89 | -280.219,58 | -33,7% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -521 | 516,81 | -269.257,23 | -32,4% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -465 | 528,16 | -245.592,63 | -29,5% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -440 | 521,11 | -229.288,93 | -27,6% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -400 | 542,72 | -217.088,00 | -26,1% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -400 | 539,26 | -215.705,60 | -25,9% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -385 | 536,88 | -206.700,03 | -24,9% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -299 | 535,80 | -160.205,43 | -19,3% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -2.450 | 517,86 | -1.268.754,80 | -152,6% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -2.432 | 525,05 | -1.276.915,52 | -153,6% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -1.996 | 515,81 | -1.029.561,35 | -123,9% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -1.560 | 526,97 | -822.070,86 | -98,9% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -1.480 | 511,98 | -757.726,55 | -91,2% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -1.363 | 518,68 | -706.965,88 | -85,0% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -1.345 | 514,68 | -692.245,95 | -83,3% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -1.199 | 524,10 | -628.394,22 | -75,6% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -1.094 | 513,11 | -561.340,04 | -67,5% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -1.066 | 526,00 | -560.716,53 | -67,5% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -970 | 523,00 | -507.307,28 | -61,0% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -846 | 519,88 | -439.821,69 | -52,9% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -840 | 521,98 | -438.461,44 | -52,7% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -766 | 516,84 | -395.896,07 | -47,6% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -691 | 529,17 | -365.653,29 | -44,0% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -681 | 521,03 | -354.823,27 | -42,7% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -600 | 540,36 | -324.214,80 | -39,0% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -575 | 528,18 | -303.702,18 | -36,5% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -487 | 536,88 | -261.459,00 | -31,5% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -480 | 539,23 | -258.831,22 | -31,1% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -473 | 536,02 | -253.537,74 | -30,5% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -332 | 534,16 | -177.342,38 | -21,3% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -280 | 530,69 | -148.592,39 | -17,9% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -166 | 529,76 | -87.940,56 | -10,6% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -148 | 535,29 | -79.222,71 | -9,5% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -80 | 537,85 | -43.027,60 | -5,2% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -80 | 532,50 | -42.600,00 | -5,1% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -40 | 545,79 | -21.831,60 | -2,6% | |
| 2026-01-09 | FRIEDMAN PAUL A | Director | Open Market Sale | -280 | 551,24 | -154.347,59 | -18,6% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -2.044 | 517,84 | -1.058.468,03 | -127,3% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -1.578 | 515,82 | -813.968,38 | -97,9% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -1.489 | 525,12 | -781.903,08 | -94,1% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -1.335 | 524,06 | -699.622,77 | -84,2% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -1.135 | 526,95 | -598.090,86 | -71,9% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -970 | 518,67 | -503.105,83 | -60,5% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -960 | 513,12 | -492.594,82 | -59,3% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -271 | 534,18 | -144.761,45 | -17,4% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -256 | 530,45 | -135.795,84 | -16,3% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -89 | 534,93 | -47.608,98 | -5,7% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -40 | 540,26 | -21.610,40 | -2,6% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -40 | 537,84 | -21.513,60 | -2,6% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -40 | 532,50 | -21.300,00 | -2,6% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -30 | 531,05 | -15.931,50 | -1,9% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -200 | 551,24 | -110.248,40 | -13,3% | |
| 2026-01-09 | Taub Rebecca | Director | Open Market Sale | -40 | 545,79 | -21.831,60 | -2,6% | |
| 2025-12-10 | Taub Rebecca | Director | Open Market Sale | -200 | 555,39 | -111.078,00 | -13,4% | |
| 2025-12-10 | FRIEDMAN PAUL A | Director | Open Market Sale | -7.193 | 551,67 | -3.968.128,50 | -477,3% | |
| 2025-12-10 | FRIEDMAN PAUL A | Director | Open Market Sale | -5.533 | 552,74 | -3.058.332,00 | -367,9% | |
| 2025-12-10 | FRIEDMAN PAUL A | Director | Open Market Sale | -5.001 | 553,83 | -2.769.728,33 | -333,2% | |
| 2025-12-10 | FRIEDMAN PAUL A | Director | Open Market Sale | -4.316 | 550,93 | -2.377.825,96 | -286,0% | |
| 2025-12-10 | FRIEDMAN PAUL A | Director | Open Market Sale | -1.029 | 555,00 | -571.091,19 | -68,7% | |
| 2025-12-10 | FRIEDMAN PAUL A | Director | Open Market Sale | -624 | 547,75 | -341.793,63 | -41,1% | |
| 2025-12-10 | FRIEDMAN PAUL A | Director | Open Market Sale | -535 | 548,51 | -293.451,08 | -35,3% | |
| 2025-12-10 | FRIEDMAN PAUL A | Director | Open Market Sale | -409 | 549,99 | -224.944,72 | -27,1% | |
| 2025-12-10 | FRIEDMAN PAUL A | Director | Open Market Sale | -160 | 555,39 | -88.862,40 | -10,7% | |
| 2025-12-10 | Taub Rebecca | Director | Open Market Sale | -4.723 | 550,99 | -2.602.307,35 | -313,0% | |
| 2025-12-10 | Taub Rebecca | Director | Open Market Sale | -4.410 | 551,85 | -2.433.641,30 | -292,8% | |
| 2025-12-10 | Taub Rebecca | Director | Open Market Sale | -3.857 | 552,81 | -2.132.196,66 | -256,5% | |
| 2025-12-10 | Taub Rebecca | Director | Open Market Sale | -3.087 | 553,88 | -1.709.826,02 | -205,7% | |
| 2025-12-10 | Taub Rebecca | Director | Open Market Sale | -1.027 | 554,84 | -569.822,43 | -68,5% | |
| 2025-12-10 | Taub Rebecca | Director | Open Market Sale | -491 | 547,76 | -268.948,54 | -32,4% | |
| 2025-12-10 | Taub Rebecca | Director | Open Market Sale | -486 | 550,07 | -267.334,75 | -32,2% | |
| 2025-12-10 | Taub Rebecca | Director | Open Market Sale | -369 | 548,56 | -202.417,87 | -24,4% | |
| 2025-12-04 | Sibold William John | Director, Officer, President and CEO | Open Market Sale | -2.400 | 575,34 | -1.380.816,00 | -166,1% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -240 | 587,85 | -141.083,88 | -17,0% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -717 | 574,00 | -411.558,79 | -49,5% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -480 | 579,85 | -278.329,20 | -33,5% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -410 | 571,99 | -234.515,57 | -28,2% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -354 | 573,02 | -202.847,35 | -24,4% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -320 | 577,81 | -184.900,61 | -22,2% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -320 | 570,39 | -182.523,52 | -22,0% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -258 | 578,83 | -149.338,40 | -18,0% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -240 | 585,44 | -140.505,19 | -16,9% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -240 | 576,15 | -138.276,41 | -16,6% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -160 | 590,37 | -94.459,60 | -11,4% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -160 | 589,65 | -94.343,66 | -11,3% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -120 | 574,95 | -68.994,29 | -8,3% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -80 | 596,19 | -47.694,80 | -5,7% | |
| 2025-12-02 | Dier Mardi | Officer, EVP and CFO | Open Market Sale | -74 | 595,20 | -44.045,15 | -5,3% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -40 | 563,21 | -22.528,40 | -2,7% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -894 | 550,97 | -492.567,18 | -59,3% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -40 | 549,34 | -21.973,70 | -2,6% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -200 | 559,60 | -111.919,60 | -13,5% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -40 | 553,23 | -22.129,13 | -2,7% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -200 | 552,38 | -110.476,80 | -13,3% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -144 | 547,27 | -78.806,64 | -9,5% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -120 | 556,04 | -66.724,80 | -8,0% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -120 | 548,71 | -65.845,20 | -7,9% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -80 | 564,57 | -45.165,20 | -5,4% | |
| 2025-11-21 | Huntsman Carole | Officer, Chief Commercial Officer | Open Market Sale | -80 | 560,62 | -44.849,60 | -5,4% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -440 | 528,60 | -232.585,58 | -28,0% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -40 | 530,21 | -21.208,40 | -2,6% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -120 | 526,68 | -63.201,96 | -7,6% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -146 | 514,67 | -75.142,40 | -9,0% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -153 | 524,49 | -80.247,05 | -9,7% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -200 | 527,85 | -105.569,68 | -12,7% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -308 | 520,68 | -160.369,38 | -19,3% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -645 | 517,51 | -333.795,95 | -40,2% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -811 | 523,66 | -424.687,37 | -51,1% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -835 | 518,53 | -432.974,14 | -52,1% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -919 | 515,64 | -473.876,19 | -57,0% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -1.094 | 521,79 | -570.835,74 | -68,7% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -1.355 | 519,67 | -704.146,62 | -84,7% | |
| 2025-11-13 | Levy Richard S | Director | Open Market Sale | -1.434 | 522,70 | -749.557,11 | -90,2% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -1.008 | 485,54 | -489.421,09 | -58,9% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -933 | 489,95 | -457.119,15 | -55,0% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -827 | 486,73 | -402.529,60 | -48,4% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -696 | 489,09 | -340.409,42 | -40,9% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -30 | 490,98 | -14.729,45 | -1,8% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -3.259 | 481,13 | -1.567.994,85 | -188,6% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -2.775 | 487,49 | -1.352.795,85 | -162,7% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -2.069 | 483,41 | -1.000.169,91 | -120,3% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -1.931 | 484,78 | -936.104,97 | -112,6% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -1.763 | 480,24 | -846.662,59 | -101,9% | |
| 2025-11-05 | BATE KENNETH | Director | Open Market Sale | -1.284 | 482,41 | -619.417,26 | -74,5% | |
| 2025-09-09 | Sibold William John | Director, Officer, President and CEO | Open Market Sale | -7.279 | 445,63 | -3.243.740,77 | -390,2% | |
| 2025-08-21 | Sibold William John | Director, Officer, President and CEO | Open Market Sale | -6.485 | 400,03 | -2.594.225,03 | -312,1% | |
| 2025-08-21 | Sibold William John | Director, Officer, President and CEO | Open Market Sale | -1.131 | 401,00 | -453.531,34 | -54,6% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 2.506 | 389,89 | 977.058,83 | +117,5% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 1.919 | 380,78 | 730.716,82 | +87,9% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 1.248 | 385,06 | 480.551,51 | +57,8% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 1.136 | 382,29 | 434.280,42 | +52,2% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 873 | 381,12 | 332.719,16 | +40,0% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 862 | 392,24 | 338.113,38 | +40,7% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 480 | 380,44 | 182.609,52 | +22,0% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 409 | 387,07 | 158.310,81 | +19,0% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 373 | 383,79 | 143.152,63 | +17,2% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 366 | 389,00 | 142.374,00 | +17,1% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 262 | 382,82 | 100.299,18 | +12,1% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 231 | 389,89 | 90.064,08 | +10,8% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 176 | 380,78 | 67.017,28 | +8,1% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 105 | 382,29 | 40.140,36 | +4,8% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 34 | 389,00 | 13.226,00 | +1,6% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 13.545 | 385,06 | 5.215.601,13 | +627,4% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 9.477 | 381,12 | 3.611.889,40 | +434,5% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 9.362 | 392,24 | 3.672.178,03 | +441,7% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 4.441 | 387,07 | 1.718.968,99 | +206,8% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 5.209 | 380,44 | 1.981.693,73 | +238,4% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 4.049 | 383,79 | 1.553.954,37 | +186,9% | |
| 2025-08-20 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 2.838 | 382,82 | 1.086.446,85 | +130,7% | |
| 2025-08-18 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 502 | 361,37 | 181.409,55 | +21,8% | |
| 2025-08-18 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 10.128 | 372,16 | 3.769.209,13 | +453,4% | |
| 2025-08-18 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 8.514 | 359,39 | 3.059.872,85 | +368,1% | |
| 2025-08-18 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 8.328 | 357,02 | 2.973.289,21 | +357,7% | |
| 2025-08-18 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 5.587 | 362,39 | 2.024.662,31 | +243,6% | |
| 2025-08-18 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 5.494 | 371,01 | 2.038.301,47 | +245,2% | |
| 2025-08-18 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 5.443 | 361,37 | 1.966.956,50 | +236,6% | |
| 2025-08-18 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 4.798 | 367,77 | 1.764.565,26 | +212,3% | |
| 2025-08-18 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 2.772 | 363,75 | 1.008.307,79 | +121,3% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 1018 von typischerweise 8355 Fonds (12 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 2.141.701 | 0 | 2.141.701 | 1.121.116.222 | Neu | +100,0% | |
| Janus Henderson Group Ltd. | 2.018.647 | 0 | 2.018.647 | 1.051.727.476 | Neu | +100,0% | |
| RTW INVESTMENTS, LP | 1.993.687 | 0 | 1.993.687 | 1.043.635.334 | Neu | +100,0% | |
| Avoro Capital Advisors LLC | 1.818.181 | 0 | 1.818.181 | 951.763.208 | Neu | +100,0% | |
| BlackRock, Inc. | 1.559.965 | 0 | 1.559.965 | 816.594.622 | Neu | +100,0% | |
| PAULSON & CO. INC. | 1.392.188 | 0 | 1.392.188 | 728.768.652 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 827.144 | 0 | 827.144 | 432.985.070 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 694.958 | 0 | 694.958 | 363.789.664 | Neu | +100,0% | |
| STATE STREET CORP | 609.525 | 0 | 609.525 | 319.068.052 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 602.543 | 0 | 602.543 | 315.413.184 | Neu | +100,0% | |
| FMR LLC | 511.728 | 0 | 511.728 | 267.873.994 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 455.870 | 0 | 455.870 | 238.681.931 | Neu | +100,0% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 340.519 | 0 | 340.519 | 178.251.481 | Neu | +100,0% | |
| Polar Capital Holdings Plc | 289.310 | 0 | 289.310 | 151.445.106 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 277.371 | 0 | 277.371 | 145.195.396 | Neu | +100,0% | |
| ARMISTICE CAPITAL, LLC | 264.583 | 0 | 264.583 | 138.501.263 | Neu | +100,0% | |
| Hood River Capital Management LLC | 249.511 | 0 | 249.511 | 130.611.523 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 240.616 | 0 | 240.616 | 125.955.258 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 239.238 | 0 | 239.238 | 125.233.916 | Neu | +100,0% | |
| Point72 Asset Management, L.P. | 234.910 | 0 | 234.910 | 122.968.338 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 216.720 | 0 | 216.720 | 113.446.418 | Neu | +100,0% | |
| MORGAN STANLEY | 191.294 | 0 | 191.294 | 100.137.080 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 189.527 | 0 | 189.527 | 99.211.699 | Neu | +100,0% | |
| Pictet Asset Management Holding SA | 187.240 | 0 | 187.240 | 97.913.702 | Neu | +100,0% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 185.331 | 0 | 185.331 | 97.015.219 | Neu | +100,0% | |
| Artisan Partners Limited Partnership | 183.540 | 0 | 183.540 | 96.077.684 | Neu | +100,0% | |
| Fiera Capital Corp | 174.011 | 0 | 174.011 | 91.089.538 | Neu | +100,0% | |
| Rock Springs Capital Management LP | 170.999 | 0 | 170.999 | 89.512.847 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 163.933 | 0 | 163.933 | 85.814.980 | Neu | +100,0% | |
| Erste Asset Management GmbH | 160.210 | 0 | 160.210 | 80.960.521 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 149.214 | 0 | 149.214 | 78.109.054 | Neu | +100,0% | |
| Caption Management, LLC | 140.000 | 0 | 140.000 | 73.285.800 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 125.447 | 0 | 125.447 | 73.052.806 | Neu | +100,0% | |
| TORONTO DOMINION BANK | 130.460 | 0 | 130.460 | 68.291.896 | Neu | +100,0% | |
| Assenagon Asset Management S.A. | 124.214 | 16.033 | 108.181 | 66.696.707 | Aufgestockt | +674,7% | |
| D. E. Shaw & Co., Inc. | 127.339 | 0 | 127.339 | 66.658.147 | Neu | +100,0% | |
| Woodline Partners LP | 125.899 | 0 | 125.899 | 65.904.350 | Neu | +100,0% | |
| UBS Group AG | 117.779 | 0 | 117.779 | 61.653.773 | Neu | +100,0% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 110.960 | 0 | 110.960 | 58.084.231 | Neu | +100,0% | |
| Tri Locum Partners LP | 103.288 | 0 | 103.288 | 54.068.169 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 98.181 | 0 | 98.181 | 51.395.973 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 98.067 | 0 | 98.067 | 51.335.132 | Neu | +100,0% | |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 94.813 | 0 | 94.813 | 49.631.761 | Neu | +100,0% | |
| 683 Capital Management, LLC | 90.000 | 0 | 90.000 | 47.112.300 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 89.300 | 0 | 89.300 | 46.745.871 | Neu | +100,0% | |
| Logos Global Management LP | 85.000 | 0 | 85.000 | 44.494.950 | Neu | +100,0% | |
| Candriam S.C.A. | 84.948 | 0 | 84.948 | 44.467.730 | Neu | +100,0% | |
| ALKEON CAPITAL MANAGEMENT LLC | 80.000 | 0 | 80.000 | 41.877.600 | Neu | +100,0% | |
| NEW YORK STATE COMMON RETIREMENT FUND | 75.129 | 0 | 75.129 | 39.327.778 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 74.041 | 0 | 74.041 | 38.758.241 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 1018 von typischerweise 8355 Fonds (12 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| Assenagon Asset Management S.A. | 124.214 | 16.033 | +674,7% | 66.696.707 | 85,30 | 100 % | 13 Q |
| Hennion & Walsh Asset Management, Inc. | 8.684 | 8.616 | +0,8% | 4.662.874 | 5,96 | 100 % | 17 Q |
| Y-Intercept (Hong Kong) Ltd | 5.560 | 0 | +100,0% | 2.985.442 | 3,82 | 100 % | 5 Q |
| TOTH FINANCIAL ADVISORY CORP | 2.000 | 2.000 | 0,0% | 1.073.900 | 1,37 | 0 % | 3 Q |
| TEMA ETFS LLC | 1.499 | 1.551 | -3,4% | 804.888 | 1,03 | 100 % | 7 Q |
| Central Pacific Bank - Trust Division | 1.145 | 0 | +100,0% | 614.808 | 0,79 | 0 % | 1 Q |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 615 | 0 | +100,0% | 330.071 | 0,42 | 2 % | 6 Q |
| PSP Research LLC | 600 | 600 | 0,0% | 322.170 | 0,41 | 0 % | 3 Q |
| Kozak & Associates, Inc. | 424 | 424 | 0,0% | 218.101 | 0,28 | 100 % | 6 Q |
| CoreCap Advisors, LLC | 280 | 277 | +1,1% | 150.346 | 0,19 | 0 % | 11 Q |
| HARBOR INVESTMENT ADVISORY, LLC | 208 | 14 | +1385,7% | 111.686 | 0,14 | 100 % | 3 Q |
| GAMMA Investing LLC | 172 | 127 | +35,4% | 92.355 | 0,12 | 100 % | 11 Q |
| EASTERN BANK | 65 | 86 | -24,4% | 34.902 | 0,04 | 100 % | 8 Q |
| Aventura Private Wealth, LLC | 62 | 62 | 0,0% | 33.291 | 0,04 | 100 % | 7 Q |
| CITY HOLDING CO | 40 | 40 | 0,0% | 21.478 | 0,03 | 100 % | 3 Q |
| CONTRAVISORY INVESTMENT MANAGEMENT, INC. | 23 | 23 | 0,0% | 12.350 | 0,02 | 100 % | 3 Q |
| MassMutual Private Wealth & Trust, FSB | 11 | 10 | +10,0% | 5.906 | 0,01 | 100 % | 11 Q |
| Dogwood Wealth Management LLC | 9 | 6 | +50,0% | 4.833 | 0,01 | 100 % | 2 Q |
| LRI Investments, LLC | 7 | 7 | 0,0% | 3.759 | 0,00 | 100 % | 2 Q |
| Signature Resources Capital Management, LLC | 7 | 7 | 0,0% | 3.759 | 0,00 | 0 % | 4 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 23 | 0,2 | 78 |
| 31.03.2026 | ✓ | 378 | 26,8 | 13.623 |
| 31.12.2025 | ✓ | 385 | 25,9 | 14.632 |
| 30.09.2025 | ✓ | 350 | 24,1 | 10.727 |
| 30.06.2025 | ✓ | 302 | 23,8 | 6.908 |
| 31.03.2025 | ✓ | 313 | 24,6 | 7.827 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 827.144 | 432.985.070 |
| TORONTO DOMINION BANK | 130.460 | 68.291.896 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 94.813 | 49.631.761 |
| Logos Global Management LP | 85.000 | 44.494.950 |
| Vestal Point Capital, LP | 31.468 | 16.472.554 |
| Integral Health Asset Management, LLC | 25.000 | 13.086.750 |
| Clearbridge Investments, LLC | 24.447 | 12.797.271 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 15.963 | 8.356.152 |
| Eversept Partners, LP | 10.000 | 5.234.700 |
| Magnetar Financial LLC | 3.811 | 1.994.944 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| Janus Henderson Group Ltd. | 2.018.647 | 433.804 | +27.4 % | 1.051.727.476 |
| CITADEL ADVISORS LLC | 453.843 | 417.709 | +1156.0 % | 237.573.195 |
| WELLINGTON MANAGEMENT GROUP LLP | 694.958 | 233.556 | +50.6 % | 363.789.664 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 185.331 | 162.105 | +697.9 % | 97.015.219 |
| ALLIANCEBERNSTEIN L.P. | 125.447 | 103.535 | +472.5 % | 73.052.806 |
| Point72 Asset Management, L.P. | 225.510 | 99.075 | +78.4 % | 118.047.720 |
| FMR LLC | 511.728 | 72.330 | +16.5 % | 267.873.994 |
| AMERIPRISE FINANCIAL INC | 98.181 | 68.894 | +235.2 % | 51.395.973 |
| MORGAN STANLEY | 191.294 | 40.832 | +27.1 % | 100.137.080 |
| MILLENNIUM MANAGEMENT LLC | 40.853 | 33.875 | +485.5 % | 21.385.320 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| PAULSON & CO. INC. | 1.392.188 | -315.334 | -18.5 % | 728.768.652 |
| BANK OF AMERICA CORP /DE/ | 189.527 | -226.498 | -54.4 % | 99.211.699 |
| ALKEON CAPITAL MANAGEMENT LLC | 80.000 | -160.000 | -66.7 % | 41.877.600 |
| DEUTSCHE BANK AG\ | 98.067 | -94.042 | -49.0 % | 51.335.132 |
| BlackRock, Inc. | 1.559.965 | -84.785 | -5.2 % | 816.594.622 |
| D. E. Shaw & Co., Inc. | 30.139 | -58.415 | -66.0 % | 15.776.863 |
| JANE STREET GROUP, LLC | 35.838 | -57.276 | -61.5 % | 18.760.118 |
| Nuveen, LLC | 62.060 | -56.303 | -47.6 % | 32.486.548 |
| Ensign Peak Advisors, Inc | 881 | -50.129 | -98.3 % | 461.177 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 22.216 | -42.250 | -65.5 % | 11.629.410 |
Zusätzlich aktuell von 211 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck | Δ-Balken |
|---|---|---|---|---|---|---|---|
| 15.05.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 8,80 % | 2.018.647 | +1,80 pp | – | |
| 15.05.2026 | PAULSON & CO. INC. | Passiv (13G/A) | 6,10 % | 1.392.188 | -1,40 pp | – | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -7,98 pp | – | |
| 17.02.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 7,00 % | 1.584.843 | -1,30 pp | – | |
| 17.02.2026 | PAULSON & CO. INC. | Passiv (13G/A) | 7,50 % | 1.707.522 | -1,90 pp | – | |
| 12.12.2025 | Rebecca Taub, M.D. | Aktivist (13D/A) | 7,80 % | 1.814.831 | Neu | No changes, except that the Reporting Person no longer serves as Chief Medical Officer o… | |
| 12.12.2025 | Paul A Friedman, M.D. | Aktivist (13D/A) | 7,80 % | 1.814.831 | Neu | No changes, except that the Reporting Person no longer serves as Chairman of the Board a… | |
| 14.11.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 8,30 % | 1.842.690 | -1,60 pp | – | |
| 14.08.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 9,90 % | 2.191.753 | -0,10 pp | – | |
| 14.05.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 10,00 % | 2.205.984 | -0,10 pp | – | |
| 14.02.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 10,10 % | 2.208.394 | Neu | – | |
| 14.11.2024 | PAULSON & CO. INC. | Passiv (13G/A) | 9,40 % | 2.042.000 | +3,80 pp | – | |
| 14.11.2024 | Roderick Wong, M.D. (+1) | Passiv (13G) | 9,20 % | 1.993.687 | Neu | – | |
| 25.03.2024 | Baker Bros. Advisors (GP) LLC (+3) | Aktivist (13D/A) | 9,99 % | 2.070.544 | 0,00 pp | – | |
| 14.02.2024 | Armistice Capital, LLC (+1) | Passiv (13G/A) | 0,25 % | 50.000 | -0,96 pp | – | |
| 14.02.2024 | PAULSON & CO. INC. | Passiv (13G/A) | 5,60 % | 1.105.741 | +0,50 pp | – | |
| 14.02.2024 | Avoro Capital Advisors LLC (+1) | Passiv (13G/A) | 9,90 % | 2.288.888 | +0,20 pp | – | |
| 13.02.2024 | Janus Henderson Group plc | Passiv (13G/A) | 14,70 % | 2.902.050 | -0,70 pp | – | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 7,98 % | 1.574.742 | +0,58 pp | – | |
| 29.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 6,10 % | 1.212.562 | +0,30 pp | – | |
| 22.01.2024 | : STATE STREET CORPORATION | Passiv (13G/A) | 3,55 % | 0 | -3,82 pp | – | |
| 13.12.2023 | Bay City Capital LLC | Aktivist (13D/A) | 0,00 % | 1.261 | -8,80 pp | – | |
| 13.12.2023 | Fred B. Craves | Aktivist (13D/A) | 2,90 % | 567.644 | -9,00 pp | – | |
| 13.12.2023 | Bay City Capital Management IV LLC (+1) | Aktivist (13D/A) | Ausstieg | 0 | -8,80 pp | – | |
| 21.11.2023 | Baker Bros. Advisors (GP) LLC (+3) | Aktivist (13D/A) | 9,99 % | 1.987.702 | 0,00 pp | – | |
| 13.11.2023 | PAULSON & CO. INC. | Passiv (13G) | 5,10 % | 1.000.000 | Neu | – | |
| 10.10.2023 | Janus Henderson Group plc | Passiv (13G/A) | 15,40 % | 3.042.661 | +5,10 pp | – | |
| 05.10.2023 | Baker Bros. Advisors (GP) LLC (+3) | Aktivist (13D/A) | 9,99 % | 2.015.760 | +1,59 pp | – | |
| 08.09.2023 | Janus Henderson Group plc | Passiv (13G) | 10,30 % | 1.910.301 | Neu | – | |
| 08.08.2023 | Baker Bros. Advisors (GP) LLC (+3) | Aktivist (13D/A) | 8,40 % | 1.545.113 | 0,00 pp | – | |
| 20.06.2023 | Baker Bros. Advisors (GP) LLC (+3) | Aktivist (13D) | 8,40 % | 1.545.113 | -0,60 pp | – | |
| 14.02.2023 | Armistice Capital, LLC (+1) | Passiv (13G/A) | 1,21 % | 208.000 | -5,39 pp | – | |
| 14.02.2023 | Deep Track Biotechnology Master Fund, Ltd. (+2) | Passiv (13G/A) | Ausstieg | 0 | -5,37 pp | – | |
| 14.02.2023 | Baker Bros. Advisors (GP) LLC (+3) | Passiv (13G/A) | 9,00 % | 1.545.113 | -0,70 pp | – | |
| 14.02.2023 | Avoro Capital Advisors LLC (+1) | Passiv (13G/A) | 9,70 % | 1.660.000 | +1,40 pp | – | |
| 09.02.2023 | The Vanguard Group | Passiv (13G/A) | 7,40 % | 1.266.375 | +0,83 pp | – | |
| 06.02.2023 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 0,19 % | 31.830 | -7,54 pp | – | |
| 02.02.2023 | : SSGA FUNDS MANAGEMENT, INC. | Passiv (13G) | 6,01 % | 0 | Neu | – | |
| 02.02.2023 | : STATE STREET CORPORATION | Passiv (13G) | 7,37 % | 0 | Neu | – | |
| 01.02.2023 | . BlackRock, Inc. | Passiv (13G/A) | 5,80 % | 986.572 | +0,20 pp | – |
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | – | -94.391.000 $ | -3,25 $ | 1.227.327.000 $ | 543.454.000 $ |
| 2025-12-31 | 10-K | – | -288.284.000 $ | -12,85 $ | 1.259.589.000 $ | 602.689.000 $ |
| 2025-09-30 | 10-Q | – | -114.190.000 $ | -4,01 $ | 1.362.457.000 $ | 625.732.000 $ |
| 2025-06-30 | 10-Q | – | -42.281.000 $ | -1,50 $ | 1.015.381.000 $ | 695.978.000 $ |
| 2025-03-31 | 10-Q | 137.250.000 $ | -73.238.000 $ | -2,61 $ | 996.629.000 $ | 710.637.000 $ |
| 2024-12-31 | 10-K | 180.133.000 $ | -465.892.000 $ | -21,90 $ | 1.042.247.000 $ | 754.383.000 $ |
| 2024-09-30 | 10-Q | – | -106.964.000 $ | -4,92 $ | 1.073.265.000 $ | 777.155.000 $ |
| 2024-06-30 | 10-Q | – | -151.971.000 $ | -7,10 $ | 1.099.789.000 $ | 857.120.000 $ |
| 2024-03-31 | 10-Q | 0 $ | -147.541.000 $ | -7,38 $ | 1.082.280.000 $ | 850.759.000 $ |
| 2023-12-31 | 10-K | 0 $ | -373.630.000 $ | -19,99 $ | 640.547.000 $ | 405.333.000 $ |
| 2023-09-30 | 10-Q | – | -98.740.000 $ | -5,34 $ | 237.964.000 $ | 22.249.000 $ |
| 2023-06-30 | 10-Q | – | -85.800.000 $ | -4,69 $ | 302.461.000 $ | 103.506.000 $ |
| 2023-03-31 | 10-Q | 0 $ | -76.896.000 $ | -4,23 $ | 332.449.000 $ | 150.136.000 $ |
| 2022-12-31 | 10-K | 0 $ | -295.350.000 $ | -17,23 $ | 362.572.000 $ | 197.389.000 $ |
| 2022-12-31 | 10-K/A | – | -295.350.000 $ | -17,23 $ | 362.572.000 $ | 197.389.000 $ |
| 2022-09-30 | 10-Q | – | -81.197.000 $ | -4,75 $ | 158.644.000 $ | 10.670.000 $ |
| 2022-06-30 | 10-Q | – | -70.730.000 $ | -4,14 $ | 216.392.000 $ | 83.535.000 $ |
| 2022-03-31 | 10-Q | – | -57.518.000 $ | -3,36 $ | 222.662.000 $ | 145.744.000 $ |
| 2021-12-31 | 10-K | 0 $ | -241.846.000 $ | -14,63 $ | 273.332.000 $ | 196.107.000 $ |
| 2021-12-31 | 10-K/A | – | -241.846.000 $ | -14,63 $ | 273.332.000 $ | 196.107.000 $ |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 06.05.2026 | 311,3 Mio. USD | -3,25 |
| Q3 2025 | 30.09.2025 | 04.11.2025 | 287,3 Mio. USD | -4,01 |
| Q2 2025 | 30.06.2025 | 05.08.2025 | 212,8 Mio. USD | -1,50 |
| Q1 2025 | 31.03.2025 | 01.05.2025 | 137,3 Mio. USD | -2,61 |
| Q3 2024 | 30.09.2024 | 31.10.2024 | 62,2 Mio. USD | -4,92 |
| Q2 2024 | 30.06.2024 | 07.08.2024 | 14,6 Mio. USD | -7,10 |
| Q1 2024 | 31.03.2024 | 07.05.2024 | 0 USD | -7,38 |
| Q3 2023 | 30.09.2023 | 06.11.2023 | 0 USD | -5,34 |
| Q2 2023 | 30.06.2023 | 08.08.2023 | 0 USD | -4,69 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 06.05.2026 | 10-Q | 31.03.2026 | 36 Tage | SEC » |
| 19.02.2026 | 10-K | 31.12.2025 | 50 Tage | SEC » |
| 04.11.2025 | 10-Q | 30.09.2025 | 35 Tage | SEC » |
| 05.08.2025 | 10-Q | 30.06.2025 | 36 Tage | SEC » |
| 01.05.2025 | 10-Q | 31.03.2025 | 31 Tage | SEC » |
| 26.02.2025 | 10-K | 31.12.2024 | 57 Tage | SEC » |
| 31.10.2024 | 10-Q | 30.09.2024 | 31 Tage | SEC » |
| 07.08.2024 | 10-Q | 30.06.2024 | 38 Tage | SEC » |
| 07.05.2024 | 10-Q | 31.03.2024 | 37 Tage | SEC » |
| 28.02.2024 | 10-K | 31.12.2023 | 59 Tage | SEC » |
| 06.11.2023 | 10-Q | 30.09.2023 | 37 Tage | SEC » |
| 08.08.2023 | 10-Q | 30.06.2023 | 39 Tage | SEC » |
| 09.05.2023 | 10-Q | 31.03.2023 | 39 Tage | SEC » |
| 03.03.2023 | 10-K/A | 31.12.2022 | 62 Tage | SEC » |
| 23.02.2023 | 10-K | 31.12.2022 | 54 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 09.05.2022 | 10-Q | 31.03.2022 | 39 Tage | SEC » |
| 24.02.2022 | 10-K | 31.12.2021 | 55 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 25.02.2021 | 10-K | 31.12.2020 | 56 Tage | SEC » |
| 05.11.2020 | 10-Q | 30.09.2020 | 36 Tage | SEC » |
| 06.08.2020 | 10-Q | 30.06.2020 | 37 Tage | SEC » |
Kapitalerhöhungen & Emissions-Historie
Emissions-Historie aus den finalen SEC-Prospekten: Börsengang (424B4) und Kapitalerhöhungen (424B5, Folge-/Sekundärplatzierungen). Volumen = Brutto-Erlös (bei Börsengängen zusätzlich der Ausgabepreis). Wiederholte Kapitalerhöhungen deuten auf Verwässerung der Altaktionäre hin.
| Datum (US) | Art | Volumen | |
|---|---|---|---|
| 07.05.2024 | Kapitalerhöhung | – | SEC » |
| 20.03.2024 | Kapitalerhöhung | – | SEC » |
| 18.03.2024 | Kapitalerhöhung | – | SEC » |
| 02.10.2023 | Kapitalerhöhung | – | SEC » |
| 28.09.2023 | Kapitalerhöhung | – | SEC » |
| 09.05.2023 | Kapitalerhöhung | – | SEC » |
| 23.12.2022 | Kapitalerhöhung | – | SEC » |
| 01.06.2021 | Kapitalerhöhung | – | SEC » |
| 05.11.2020 | Kapitalerhöhung | – | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Beträge in US-Dollar.
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | Form | |
|---|---|---|---|
| 28.04.2026 | HV-Einladung | DEF 14A | SEC » |
| 28.04.2026 | HV-Einladung | DEFA14A | SEC » |
| 29.04.2025 | HV-Einladung | DEFA14A | SEC » |
| 29.04.2025 | HV-Einladung | DEF 14A | SEC » |
| 29.04.2024 | HV-Einladung | DEFA14A | SEC » |
| 29.04.2024 | HV-Einladung | DEF 14A | SEC » |
| 01.05.2023 | HV-Einladung | DEFA14A | SEC » |
| 01.05.2023 | HV-Einladung | DEF 14A | SEC » |
| 21.04.2023 | Vorläufig | PRE 14A | SEC » |
| 02.05.2022 | HV-Einladung | DEFA14A | SEC » |
| 02.05.2022 | HV-Einladung | DEF 14A | SEC » |
| 30.04.2021 | HV-Einladung | DEFA14A | SEC » |
| 30.04.2021 | HV-Einladung | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termine und Vergütung stehen im Dokument (SEC-Link).
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 27.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Proxy Statement is incorporated by reference into Item 5.02 of this Current Report on Form 8-K. The summary is… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-30 | 208.494 | 527,28 | 109.934.716 |
| 2026-06-29 | 208.700 | 512,65 | 106.990.055 |
| 2026-06-26 | 2.145 | 513,79 | 1.102.080 |
| 2026-06-15 | 2.426 | 480,77 | 1.166.348 |
| 2026-06-12 | 5.930 | 474,28 | 2.812.480 |
| 2026-06-08 | 1.997 | 486,98 | 972.499 |
| 2026-06-05 | 363 | 492,83 | 178.897 |
| 2026-05-26 | 268 | 517,26 | 138.626 |
| 2026-05-14 | 97 | 518,87 | 50.330 |
| 2026-04-21 | 243 | 527,11 | 128.088 |
| 2026-04-07 | 4.628 | 533,88 | 2.470.797 |
| 2026-04-02 | 158 | 529,84 | 83.715 |
| 2026-03-27 | 524 | 518,76 | 271.830 |
| 2026-03-26 | 373 | 461,93 | 172.300 |
| 2026-03-25 | 118 | 445,04 | 52.515 |
| 2026-03-23 | 539 | 441,16 | 237.785 |
| 2026-03-20 | 149 | 454,22 | 67.679 |
| 2026-03-13 | 4 | 438,73 | 1.755 |
| 2026-03-02 | 5 | 432,00 | 2.160 |
| 2026-02-27 | 282 | 445,85 | 125.730 |
| 2026-02-23 | 117 | 435,01 | 50.896 |
| 2026-02-20 | 2.898 | 436,87 | 1.266.049 |
| 2026-02-10 | 167 | 488,26 | 81.539 |
| 2026-02-09 | 167 | 477,60 | 79.759 |
| 2026-02-02 | 1.133 | 489,31 | 554.388 |
| 2026-01-30 | 3.019 | 494,69 | 1.493.469 |
| 2026-01-27 | 3.064 | 499,17 | 1.529.457 |
| 2026-01-26 | 2.499 | 480,45 | 1.200.645 |
| 2026-01-23 | 12.071 | 498,04 | 6.011.841 |